Drug News

TING 1% Athlete’s Foot Spray Recalled Due to Elevated Benzene Levels

Insight Pharmaceuticals is recalling two lots of TING 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid due to elevated levels of benzene discovered during a recent review by their manufacturer and third-party lab. While benzene is not an ingredient, it was found in the propellant of the affected lots (0H50545 and 1G50645). No other TING 1% Tolnaftate Athlete’s Foot Spray products are affected.

Benzene is a human carcinogen, and exposure can lead to serious health issues, including various cancers. The affected lots were distributed nationwide in the United States through limited retailers and online platforms.

TING 1 Athletes Foot Spray Recalled Due to Elevated Benzene Levels

As of now, the company has not received any reports of serious adverse events related to this recall. The recalled product is used for the treatment of athlete’s foot, jock itch, and ringworm, providing relief from itchy, scaly skin between the toes.

Consumers with the affected lots are advised to stop using the product immediately, safely discard it after taking a picture of the can’s bottom, and contact their healthcare provider if they experience any problems related to the product. Insight Pharmaceuticals is offering a full refund for affected consumers.

For reimbursement, consumers can contact Insight Pharmaceuticals via email at medicalaffairs@prestigebrands.com, through their website, or by phone at (800) 344-7239 (Monday – Friday, 8:30 AM – 5:30 PM Eastern Time).

<

Joan David-Leonhard

Joan David Leonhard is a recent Pharm.D graduate with a strong passion for the pharmaceutical industry and a particular interest in pharmaceutical media and communication. Her brief internship experience includes roles in pharmacy where she built strong patient-pharmacist relationships and a pharmaceutical media internship where she actively contributed to drug information articles, blog posts, social media engagement, and various media projects.
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker